{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:54:42Z","timestamp":1786550082828,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1038\/ajg.2016.405","type":"journal-article","created":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T08:03:09Z","timestamp":1473753789000},"page":"1608-1613","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Birth Outcomes in Children Fathered by Men Treated with Anti-TNF-\u03b1 Agents Before Conception"],"prefix":"10.14309","volume":"111","author":[{"given":"Michael Due","family":"Larsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjarne","family":"Magnussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bente Mertz","family":"N\u00f8rg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-26-20210210","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/ajg.2012.430","article-title":"Safety of thiopurines and anti-TNF-alpha drugs during pregnancy in patients with inflammatory bowel disease.","volume":"108","author":"Casanova","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"R2-26-20210210","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1002\/ibd.21583","article-title":"Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy.","volume":"17","author":"Schnitzler","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"R3-26-20210210","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1365-2036.2011.04617.x","article-title":"High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy.","volume":"33","author":"Zelinkova","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"R4-26-20210210","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/ajg.2012.218","article-title":"Serious infection and mortality in patients with Crohns disease: more than 5 years of follow-up in the TREAT registry.","volume":"107","author":"Lichtenstein","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R5-26-20210210","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4321\/S1130-01082012000200003","article-title":"Is safety infliximb during pregnancy in patients with inflammatory bowel disease?","volume":"104","author":"Arguelles-Arias","year":"2012","journal-title":"Rev Esp Enferm Dig"},{"key":"R6-26-20210210","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.reprotox.2013.11.004","article-title":"Pregnancy outcome following gestational exposure to TNF-alpha-inhibitors: a prospective, comparative, observational study.","volume":"43","author":"Diav-Citrin","year":"2014","journal-title":"Reprod Toxicol"},{"key":"R7-26-20210210","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/bcp.12642","article-title":"Pregnancy outcome after TNF-alpha inhibitor therapy during the first trimester: a prospective multicentre cohort study.","volume":"80","author":"Weber-Schoendorfer","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"R8-26-20210210","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1136\/gutjnl-2015-309321","article-title":"Tailored anti-TNF therapy during pregnancy in patients with IBD: maternal and fetal safety.","volume":"65","author":"de Lima","year":"2015","journal-title":"Gut"},{"key":"R9-26-20210210","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1111\/j.1572-0241.2004.30186.x","article-title":"Outcome of pregnancy in women receiving infliximab for the treatment of Crohns disease and rheumatoid arthritis.","volume":"99","author":"Katz","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R10-26-20210210","first-page":"768","article-title":"Sexual and reproductive issues for men with inflammatory bowel disease.","volume":"104","author":"Feagins","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R11-26-20210210","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/apt.13142","article-title":"Review article: the safety of therapeutic drugs in male inflammatory bowel disease patients wishing to conceive.","volume":"41","author":"Sands","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"R12-26-20210210","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0095-5108(18)31161-8","article-title":"Influence of drug exposure of the father on perinatal outcome.","volume":"6","author":"Joffe","year":"1979","journal-title":"Clin Perinatol"},{"key":"R13-26-20210210","first-page":"116","article-title":"Paternal drug exposure: effects on reproduction and progeny.","volume":"6","author":"Joffe","year":"1982","journal-title":"Semin Perinatol"},{"key":"R14-26-20210210","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.fertnstert.2013.10.048","article-title":"Influence of tumor necrosis factor alpha inhibitors on testicular function and semen in spondyloarthritis patients.","volume":"101","author":"Ramonda","year":"2014","journal-title":"Fertil Steril"},{"key":"R15-26-20210210","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1136\/ard.2009.127423","article-title":"Effects of TNF antagonists on sperm characteristics in patients with spondyloarthritis.","volume":"69","author":"Villiger","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R16-26-20210210","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/rheumatology\/keu007","article-title":"TNF-alpha inhibitors do not impair sperm quality in males with ankylosing spondylitis after short-term or long-term treatment.","volume":"53","author":"Micu","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"R17-26-20210210","first-page":"765","article-title":"Impact of TNF-blocking agents on male sperm characteristics and pregnancy outcomes in fathers exposed to TNF-blocking agents at time of conception.","volume":"30","author":"Puchner","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"R18-26-20210210","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/01.MIB.0000164023.10848.c4","article-title":"Infliximab and semen quality in men with inflammatory bowel disease.","volume":"11","author":"Mahadevan","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"R19-26-20210210","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/03009742.2011.626442","article-title":"Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers.","volume":"41","author":"Viktil","year":"2012","journal-title":"Scand J Rheumatol"},{"key":"R20-26-20210210","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1365-2125.2012.04426.x","article-title":"Effects of preconceptional paternal drug exposure on birth outcomes: cohort study of 340 000 pregnancies using Norwegian population-based databases.","volume":"75","author":"Engeland","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"R21-26-20210210","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3899\/jrheum.080554","article-title":"Fertility and reproduction in male patients with ankylosing spondylitis treated with infliximab.","volume":"36","author":"Paschou","year":"2009","journal-title":"J Rheumatol"},{"key":"R22-26-20210210","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jbspin.2012.03.004","article-title":"Fertility in male patients with seronegative spondyloarthropathies treated with infliximab.","volume":"80","author":"Saougou","year":"2013","journal-title":"Joint Bone Spine"},{"key":"R23-26-20210210","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s10198-003-0165-6","article-title":"Pricing and reimbursement of drugs in Denmark.","volume":"4","author":"Pedersen","year":"2003","journal-title":"Eur J Health Econ"},{"key":"R25-26-20210210","first-page":"320","article-title":"The Danish Medical Birth Registry.","volume":"45","author":"Knudsen","year":"1998","journal-title":"Dan Med Bull"},{"key":"R28-26-20210210","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/0895-4356(96)00018-2","article-title":"Validation of the Danish Birth Registration.","volume":"49","author":"Kristensen","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"R29-26-20210210","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1651-2227.1996.tb14164.x","article-title":"Intrauterine growth curves based on ultrasonically estimated foetal weights.","volume":"85","author":"Marsal","year":"1996","journal-title":"Acta Paediatr"},{"key":"R30-26-20210210","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/14034940210134194","article-title":"Predictive value and completeness of the registration of congenital abnormalities in three Danish population-based registries.","volume":"31","author":"Larsen","year":"2003","journal-title":"Scand J Public Health"},{"key":"R31-26-20210210","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.fertnstert.2004.11.068","article-title":"Infliximab may reverse the toxic effects induced by tumor necrosis factor alpha in human spermatozoa: an in vitro model.","volume":"83","author":"Said","year":"2005","journal-title":"Fertil Steril"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg2016405.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2016405","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2016405.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201611000-00026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:13:45Z","timestamp":1786547625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201611000-00026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2016.405","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}